Compare XFOR & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XFOR | ALCO |
|---|---|---|
| Founded | 2014 | 1960 |
| Country | United States | United States |
| Employees | 45 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.3M | 305.0M |
| IPO Year | N/A | 1994 |
| Metric | XFOR | ALCO |
|---|---|---|
| Price | $4.15 | $38.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $9.00 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 583.8K | 13.6K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $31.32 |
| 52 Week High | $4.83 | $45.01 |
| Indicator | XFOR | ALCO |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 34.55 |
| Support Level | $3.58 | $37.31 |
| Resistance Level | $4.52 | $38.40 |
| Average True Range (ATR) | 0.22 | 0.70 |
| MACD | 0.04 | -0.13 |
| Stochastic Oscillator | 72.08 | 17.34 |
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.